Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Phibro Animal Health (PAHC) Raw Materials: 2013-2025

Historic Raw Materials for Phibro Animal Health (PAHC) over the last 13 years, with Jun 2025 value amounting to $162.6 million.

  • Phibro Animal Health's Raw Materials rose 116.71% to $166.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $166.4 million, marking a year-over-year increase of 116.71%. This contributed to the annual value of $162.6 million for FY2025, which is 123.39% up from last year.
  • Phibro Animal Health's Raw Materials amounted to $162.6 million in FY2025, which was up 123.39% from $72.8 million recorded in FY2024.
  • Phibro Animal Health's 5-year Raw Materials high stood at $162.6 million for FY2025, and its period low was $59.8 million during FY2021.
  • For the 3-year period, Phibro Animal Health's Raw Materials averaged around $106.6 million, with its median value being $84.3 million (2023).
  • In the last 5 years, Phibro Animal Health's Raw Materials decreased by 19.04% in 2021 and then surged by 123.39% in 2025.
  • Over the past 5 years, Phibro Animal Health's Raw Materials (Yearly) stood at $59.8 million in 2021, then spiked by 45.60% to $87.0 million in 2022, then declined by 3.10% to $84.3 million in 2023, then dropped by 13.67% to $72.8 million in 2024, then skyrocketed by 123.39% to $162.6 million in 2025.